Akili Inc Revenue Growth Rates (AKLI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Akili Inc   (NASDAQ: AKLI)
 

AKLI's Revenue Growth by Quarter and Year

Akili Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKLI Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.38
FY 0.38





AKLI Revenue first quarter 2024 Y/Y Growth Comment
Akili Inc reported Revenue surge of 248.18% year on year in the first quarter 2024, to $ 0.38 millions, this is lower than Akili Inc 's recent average Revenue surge of 401.94%.

Looking into first quarter 2024 results within Medical Equipment & Supplies industry 7 other companies have achieved higher Revenue growth. While Akili Inc ' s Revenue doubling of 248.18% ranks overall at the positon no. 139 in the first quarter 2024.


AKLI Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - 581.82 % - -
3rd Quarter September - 775 % -50 % -
2nd Quarter June - 83.33 % - -
1st Quarter March 248.18 % 57.14 % - -
FY   - 421.88 % 100 % -

Financial Statements
Akili Inc 's first quarter 2024 Revenue $ 0.38 millions AKLI's Income Statement
Akili Inc 's first quarter 2023 Revenue $ 0.11 millions Quarterly AKLI's Income Statement


AKLI Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - 7.14 % 37.5 % -
3rd Quarter September - 536.36 % 33.33 % -
2nd Quarter June - 0 % -14.29 % -
1st Quarter March -48.93 % 0 % - -
FY (Year on Year)   - 421.88 % 100 % -


Back to AKLI Growth rate Comparisons >> Back to AKLI Growth rate Comparisons >>


Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #48
Overall #139

Revenue Y/Y Growth Statistics
High Average Low
756.1 % 401.94 % 210.79 %
 
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #48
Overall #139
Revenue Y/Y Growth Statistics
High Average Low
756.1 % 401.94 % 210.79 %
 

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Akili Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
515.79 % 102.55 % -53.11 %
(Sep 30 2023)  


AKLI's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Akili Inc disclosed fall in Revenue from the fourth quarter by -48.93% to $ 0.38 millions, from $ 0.75 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 164 other companies have achieved higher Revenue quarter on quarter growth. While Akili Inc 's Revenue growth quarter on quarter, overall rank is 3399.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #165
Healthcare Sector #489
Overall #3399
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #165
Healthcare Sector #489
Overall #3399
Revenue Q/Q Growth Statistics
High Average Low
515.79 % 102.55 % -53.11 %
(Sep 30 2023)  


AKLI's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Akili Inc disclosed fall in Revenue from the fourth quarter by -48.93% to $ 0.38 millions, from $ 0.75 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 164 other companies have achieved higher Revenue quarter on quarter growth. While Akili Inc 's Revenue growth quarter on quarter, overall rank is 3399.


Akili Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 1.95 $ 1.68 $ 1.04 $ 0.42 $ 0.37
Y / Y Revenue Growth (TTM) 426.49 % 419.5 % - - -
Year on Year Revenue Growth Overall Ranking # 41 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 16.09 % 61.35 % 147.62 % 13.51 % 14.55 %
Seq. Revenue Growth (TTM) Overall Ranking # 123 # 0 # 213 # 0 # 0


Cumulative Revenue growth Comment
With 426.49% annual Revenue growth, Akili Inc would report a record annual Revenue surge if the fiscal year would end on Mar 31 2024.

Among companies within the Healthcare sector 15 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 41.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 5
Healthcare Sector # 16
Overall # 41

Revenue TTM Y/Y Growth Statistics
High Average Low
426.49 %
 423 %
419.5 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 39
S&P 500 # 123
Cumulative Revenue growth Comment
With 426.49% annual Revenue growth, Akili Inc would report a record annual Revenue surge if the fiscal year would end on Mar 31 2024.

Among companies within the Healthcare sector 15 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 41.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 5
Healthcare Sector # 16
Overall # 41

Revenue TTM Y/Y Growth Statistics
High Average Low
426.49 %
423 %
419.5 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 39
S&P 500 # 123




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AKLI's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Delcath Systems Inc 425.80%$ 425.796 millions
Anaptysbio Inc 422.49%$ 422.489 millions
U S Physical Therapy Inc404.50%$ 404.505 millions
Scorpius Holdings inc 358.80%$ 358.800 millions
Omega Therapeutics Inc 357.36%$ 357.364 millions
Invo Fertility Inc 352.92%$ 352.923 millions
Spero Therapeutics Inc 347.90%$ 347.898 millions
Pmgc Holdings Inc 330.39%$ 330.392 millions
Lifeward ltd 329.51%$ 329.512 millions
Verve Therapeutics Inc 305.63%$ 305.627 millions
Ardelyx inc 304.81%$ 304.811 millions
Bicycle Therapeutics Plc298.90%$ 298.897 millions
Tff Pharmaceuticals Inc295.25%$ 295.250 millions
Pulmatrix Inc 292.60%$ 292.595 millions
Apellis Pharmaceuticals Inc 284.26%$ 284.259 millions
Nuo Therapeutics Inc 283.92%$ 283.923 millions
Celularity Inc 273.09%$ 273.088 millions
Bioadaptives Inc 255.27%$ 255.273 millions
Xoma Royalty Corporation240.96%$ 240.961 millions
Akili Inc 238.94%$ 238.938 millions
Plus Therapeutics Inc 231.42%$ 231.423 millions
Vaxart Inc 223.11%$ 223.111 millions
Sensus Healthcare Inc 212.33%$ 212.332 millions
Siga Technologies Inc205.54%$ 205.536 millions
Scpharmaceuticals Inc 195.78%$ 195.783 millions
Neuroone Medical Technologies Corp195.45%$ 195.445 millions
Bespoke Extracts Inc192.56%$ 192.563 millions
Bolt Biotherapeutics Inc 188.83%$ 188.828 millions
Ascendis Pharma A188.83%$ 188.826 millions
Bioxcel Therapeutics Inc 182.52%$ 182.524 millions


About Akili Inc Revenue Growth Rates (AKLI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Akili Inc (CIK 1850266).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000950170-24-059580
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Akili Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.